U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07660536) titled 'To Study the Efficacy and Safety of Doxercalciferol on Spinal and Femoral Density in Postmenopausal Osteopenic Women in a Long Term 2 Year Study' on June 16.
Brief Summary: A clinical trial to compare the effect of doxercalciferol or placebo in preventing bone loss from the spine and femur in postmenopausal women
Study Start Date: Nov. 14, 1989
Study Type: INTERVENTIONAL
Condition:
Bone Mineral Density of Spine and Femur
Intervention:
DRUG: doxercalciferol capsules, Hectorol(R)
doxercalciferol capsules given in escalating doses from 1mcg to 5mcg daily.If serum calcium is elevated at any dose then that dose is maintained long ...